FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to pharmacology. Use of n-tyrosol as a means of improving microvascularization in brain tissue in course administration is suggested. Proposed invention extends the arsenal of means that improve microvascularization in the brain tissue.
EFFECT: improvement of microvascularization is manifested in an increase in the average diameter of the capillaries and in the proportion of capillaries passed to the erythrocytes and in the increase in the density of the capillary network.
1 cl, 2 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
MEANS FOR MICROVASCULARIZATION IMPROVEMENT IN BRAIN TISSUE | 2017 |
|
RU2644286C1 |
AGENT STIMULATING NEUROGENESIS IN ISCHEMIC CEREBRAL INJURIES | 2015 |
|
RU2585094C1 |
AGENT POSSESSING ENDOTHELIUM PROTECTIVE ACTIVITY | 2014 |
|
RU2563622C1 |
ANTI-ISCHEMIC DRUG | 2012 |
|
RU2499593C1 |
ANTIISHEMIC AGENT | 2008 |
|
RU2384327C1 |
AGENT RELIEVING POSTINFARCTION MYOCARDIAL REMODELING | 2020 |
|
RU2740895C1 |
AGENT POSSESSING NEUROPROTECTIVE ACTIVITY | 2018 |
|
RU2701739C1 |
NEUROPROTECTOR | 2009 |
|
RU2406488C1 |
PREPARATIONS IMPROVING SURVIVAL RATE IN WOUND SHOCK | 2011 |
|
RU2471489C1 |
HEMORHEOLOGICAL AND ANTITHROMBOTIC AGENT | 2003 |
|
RU2239423C1 |
Authors
Dates
2018-04-16—Published
2017-04-13—Filed